We added two media for Mesenchymal stem cells to our portfolio called CellCor, a serum free chemically defined media composed of over 200 known compounds: CellCor™ CD is an animal component-free, serum-free (SFD) & chemically defined (CD) medium for expansion and growth of MSCs. The media do only contain recombinant compounds.
Our gift to you: Order now your Sample at info@pelobiotech.com, subjectline; CellCor MSC.
Great for:
- Adipose-derived (AD)- MSCs
- Bone Marrow (BM)- MSCs
- Umbilical cord (UC)- MSCs
- Fibroblasts
- Derma Papilla Cell (DPC)
CellCor™ does not contain any animal nor plant derived components, it is hPL- and Exosome free, in R&D and GMP quality.
Your Plus:
- 200+ Compounds
- Optimal Composition for MSCs. No extra coating needed in general!
- Mass Production Process
- R&D and GMP quality
| Product | CellCor™ SFD MSC |
CellCor™ CD MSC |
|---|---|---|
| Class | Serum-Free Fully Defined |
Serum-Free Chemically Defined |
| Cell Type | Human Mesenchymal Stem Cell | |
| Advantages | Proliferation↑ Homogeneity↑ |
Stemness↑ Genetic Stability↑ |
![PELOAcademy starts now a series of FREE Webinars: Can Cell Culture be as good as in vivo? Roadmap to a better Worfkflow in your lab. We will discuss with you the most important steps during your workflow starting March each 4th Thursday of the month. See our full program till summer below. Thur March 26, […]](https://www.pelobiotech.com/wp-content/uploads/2020/03/2020_Webinar_WorkflowFlyer_Q1_2.jpg "PELOAcademy starts Cell Culture series: Part 1 – Informed Consent")
![NEW Product: Mighty Match for your MSC Culture presented by Dejan Husman, CEO denovoMatrix, Dresden. Your challenge: Are you interested in reducing or completely eliminating serum content in your media? But so far your cell performance has suffered? Using serum-containing media limits the impact of your research on human mesenchymal stromal cells (#hMSC) in non-clinical […]](https://www.pelobiotech.com/wp-content/uploads/2020/01/Pub-Quiz-Instagram-Post-1.png "PELONews: Join FREE live MSC-Webinar")
Leave a Reply